Injury to peripheral nerves can result in significant and permanent functional deficits. Nerve allografts offer a limitless source of nerve graft material that is used clinically to reconstruct severe otherwise irreparable traumatic nerve injuries. FK506 enhances nerve regeneration and is the immunosuppressant of choice for preventing allograft rejection, but can cause significant patient morbidity. The long-term objective of this proposal is to develop strategies to prevent nerve allograft rejection while minimizing the side effects of immunosuppression, thereby improving safety and broadening the clinical indications for peripheral nerve allotransplantation. Donor-specific immune unresponsiveness induced by costimulation blockade has been shown to permit nerve regeneration through allografts in several animal models while maintaining general immunocompetence. Similarly nerve allografts can be cold preserved to decrease antigenicity and seeded with host Schwann cells to facilitate nerve regeneration. A better understanding of the nerve allograft response, the effects of cold preservation, and Schwann cell migration into nerve grafts provides a basis for strategies to minimize requirements for host immunosuppression. Supplementation of nerve allografts with modified host Schwann cells may enhance regeneration through nerve allografts. These approaches will expand the indications for nerve allotransplantation to include less severe injuries where nerve autografts are currently used.
In aim 1 a the relative contributions of the direct and indirect pathways of alloantigen presentation in peripheral nerve allografts are characterized using CD4+ and CD8+ knockout and MHC class ll-deficient mice.
Aim 1 b studies the effects of cold preservation of nerve allografts on these pathways using STAT4 and STAT6 gene knockout mice.
In aim 2 a, regeneration through nerve allografts is evaluated following simultaneous blockade of CD28/B7 and CD40 costimulatory pathways.
In aim 2 b, nerve allografts are cold preserved to optimize the efficacy of costimulatory blockade to permit allograft acceptance.
In aim 3 a, Thy1-CFP/S100-GFP mice are used to characterize Schwann cell migration, differentiation, and maturation when repopulating a cold preserved nerve allograft.
In aim 3 b, nerve allografts are cold preserved for 7 weeks and then seeded with cultured autologous Schwann cells that overexpress GDNF to permit regeneration through nerve allografts without any immunosuppression.
In aim 3 c this same construct is evaluated in a long swine allograft model that closely resembles the long nerve defects encountered clinically and will allow translation to the nerve-injured patient.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS033406-17
Application #
7997200
Study Section
Clinical Neuroplasticity and Neurotransmitters Study Section (CNNT)
Program Officer
Ludwig, Kip A
Project Start
1994-08-01
Project End
2011-12-31
Budget Start
2011-01-01
Budget End
2011-12-31
Support Year
17
Fiscal Year
2011
Total Cost
$439,108
Indirect Cost
Name
Washington University
Department
Surgery
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Jesuraj, Nithya J; Santosa, Katherine B; Macewan, Matthew R et al. (2014) Schwann cells seeded in acellular nerve grafts improve functional recovery. Muscle Nerve 49:267-76
Farber, Scott J; Glaus, Simone W; Moore, Amy M et al. (2013) Supercharge nerve transfer to enhance motor recovery: a laboratory study. J Hand Surg Am 38:466-77
Saheb-Al-Zamani, Maryam; Yan, Ying; Farber, Scott J et al. (2013) Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence. Exp Neurol 247:165-77
Yan, Ying; MacEwan, Matthew R; Hunter, Daniel A et al. (2013) Nerve regeneration in rat limb allografts: evaluation of acute rejection rescue. Plast Reconstr Surg 131:499e-511e
Fox, Ida K; Brenner, Michael J; Johnson, Philip J et al. (2012) Axonal regeneration and motor neuron survival after microsurgical nerve reconstruction. Microsurgery 32:552-62
Jesuraj, Nithya J; Nguyen, Peter K; Wood, Matthew D et al. (2012) Differential gene expression in motor and sensory Schwann cells in the rat femoral nerve. J Neurosci Res 90:96-104
Gustafson, Tiffany P; Yan, Ying; Newton, Piyaraj et al. (2012) A NIR Dye for Development of Peripheral Nerve Targeted Probes. Medchemcomm 3:685-690
Yan, Ying; Sun, Hank H; Hunter, Daniel A et al. (2012) Efficacy of short-term FK506 administration on accelerating nerve regeneration. Neurorehabil Neural Repair 26:570-80
Glaus, Simone W; Johnson, Philip J; Mackinnon, Susan E (2011) Clinical strategies to enhance nerve regeneration in composite tissue allotransplantation. Hand Clin 27:495-509, ix
Fox, Ida K; Mackinnon, Susan E (2011) Adult peripheral nerve disorders: nerve entrapment, repair, transfer, and brachial plexus disorders. Plast Reconstr Surg 127:105e-118e

Showing the most recent 10 out of 69 publications